Genetics of psoriasis and pharmacogenetics of biological drugs

Autoimmune Diseases

Volumn 2013, Issue , 2013, Pages

  Prieto Pérez, Rocío ^a   Cabaleiro, Teresa ^a   Daudén, Esteban ^a   Ochoa, Dolores ^a   Roman, Manuel ^a   Abad Santos, Francisco ^a,b  

^a HOSPITAL UNIVERSITARIO DE LA PRINCESA   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ADALIMUMAB; APOLIPOPROTEIN E; APREMILAST; BIOLOGICAL PRODUCT; BRODALUMAB; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; ETANERCEPT; GAMMA INTERFERON; HLA C ANTIGEN; INFLIXIMAB; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 15; INTERLEUKIN 18; INTERLEUKIN 19; INTERLEUKIN 2; INTERLEUKIN 20; INTERLEUKIN 23 RECEPTOR; INTERLEUKIN 4; INTERLEUKIN 6; IXEKIZUMAB; MONOCYTE CHEMOTACTIC PROTEIN 1; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR KAPPA B; SECUKINUMAB; STAT4 PROTEIN; TOFACITINIB; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 3; USTEKINUMAB; VITAMIN D RECEPTOR;

ALLELE; CELL MIGRATION; CYTOKINE PRODUCTION; DRUG SAFETY; DRUG TOLERABILITY; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HUMAN; MACROPHAGE ACTIVATION; PERIPHERAL BLOOD MONONUCLEAR CELL; PHARMACOGENETICS; PHARMACOGENOMICS; PHASE 2 CLINICAL TRIAL (TOPIC); PHASE 3 CLINICAL TRIAL (TOPIC); PRIORITY JOURNAL; PSORIASIS; PSORIASIS VULGARIS; PSORIATIC ARTHRITIS; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; TREATMENT RESPONSE;

EID: 84884225001     PISSN: None     EISSN: 20900430     Source Type: Journal    
DOI: 10.1155/2013/613086     Document Type: Review

References (107)

1. Yamamoto M., Imai Y., Sakaguchi Y., Haneda T., Yamanishi K., Serum cytokines correlated with the disease severity of generalized pustular psoriasis. Disease Markers 2013 34 3 153 161
2. Julia A., Tortosa R., Hernanz J. M., Risk variants for psoriasis vulgaris in a large case-control collection and association with clinical subphenotypes. Human Molecular Genetics 2012 21 20 4549 4557
3. Schafer P., Apremilast mechanism of action and application to psoriasis and psoriatic arthritis. Biochemical Pharmacology 2012 83 12 1583 1590 2-s2.0-84860175869 10.1016/j.bcp.2012.01.001
4. Dauden E., Herrera E., Puig L., Validation of a new tool to assess health-related quality of life in psoriasis: the PSO-LIFE questionnaire. Health and Quality of Life Outcomes 2012 10 56
5. Zhang P., Zhao M., Liang G., Whole-genome DNA methylation in skin lesions from patients with psoriasis vulgaris. Journal of Autoimmunity 2013
6. Chandran V., Raychaudhuri S. P., Geoepidemiology and environmental factors of psoriasis and psoriatic arthritis. Journal of Autoimmunity 2010 34 3 J314 J321 2-s2.0-77649186719 10.1016/j.jaut.2009.12.001
7. Chandran V., Genetics of psoriasis and psoriatic arthritis. Indian Journal of Dermatology 2010 55 2 151 156 2-s2.0-77952031983 10.4103/0019-5154. 62751
8. Prieto-Perez R., Cabaleiro T., Dauden E., Abad-Santos F., Gene polymorphisms that can predict response to anti-TNF therapy in patients with psoriasis and related autoimmune diseases. Pharmacogenomics Journal 2013
9. Raychaudhuri S. P., Role of IL-17 in psoriasis and psoriatic arthritis. Clinical Reviews in Allergy & Immunology 2012 44 2 183 193
10. Ortiz-Ibanez K., Alsina M. M., Munoz-Santos C., Tofacitinib and other kinase inhibitors in the treatment of psoriasis. Actas Dermo- Sifiliográficas 2013 104 4 304 310
11. Vafadari R., Weimar W., Baan C. C., Phosphospecific flow cytometry for pharmacodynamic drug monitoring: analysis of the JAK-STAT signaling pathway. Clinica Chimica Acta 2012 413 17-18 1398 1405 2-s2.0-84856077939 10.1016/j.cca.2011.12.023
12. West K., CP-690550, a JAK3 inhibitor as an immunosuppressant for the treatment of rheumatoid arthritis, transplant rejection, psoriasis and other immune-mediated disorders. Current Opinion in Investigational Drugs 2009 10 5 491 504 2-s2.0-67649397492
13. Wojciechowski D., Vincenti F., Targeting JAK3 in kidney transplantation: current status and future options. Current Opinion in Organ Transplantation 2011 16 6 614 619 2-s2.0-81255159058 10.1097/MOT.0b013e32834c23ce
14. Vasilopoulos Y., Manolika M., Zafiriou E., Sarafidou T., Bagiatis V., Krüger-Krasagaki S., Tosca A., Patsatsi A., Sotiriadis D., Mamuris Z., Roussaki-Schulze A., Pharmacogenetic analysis of TNF, TNFRSF1A, and TNFRSF1B gene polymorphisms and prediction of response to anti-TNF therapy in psoriasis patients in the greek population. Molecular Diagnosis and Therapy 2012 16 1 29 34 2-s2.0-84857578226 10.2165/11594660
15. Tejasvi T., Stuart P. E., Chandran V., Voorhees J. J., Gladman D. D., Rahman P., Elder J. T., Nair R. P., TNFAIP3 gene polymorphisms are associated with response to TNF blockade in psoriasis. Journal of Investigative Dermatology 2012 132 3 593 600 2-s2.0-84857037386 10.1038/jid.2011.376
16. Kulski J. K., Kenworthy W., Bellgard M., Taplin R., Okamoto K., Oka A., Mabuchi T., Ozawa A., Tamiya G., Inoko H., Gene expression profiling of Japanese psoriatic skin reveals an increased activity in molecular stress and immune response signals. Journal of Molecular Medicine 2005 83 12 964 975 2-s2.0-28544442794 10.1007/s00109-005-0721-x
17. Iizuka H., Takahashi H., Honma M., Ishida-Yamamoto A., Unique keratinization process in psoriasis: late differentiation markers are abolished because of the premature cell death. Journal of Dermatology 2004 31 4 271 276 2-s2.0-2342461732
18. Krueger J. G., Fretzin S., Suarez-Farinas M., IL-17A is essential for cell activation and inflammatory gene circuits in subjects with psoriasis. Journal of Allergy and Clinical Immunology 2012 130 1 145 154
19. Hohler T., Kruger A., Schneider P. M., Schopf R. E., Knop J., Rittner C., Meyer zum Buschenfelde K.-H., Marker-Hermann E., A TNF- α promoter polymorphism is associated with juvenile onset psoriasis and psoriatic arthritis. Journal of Investigative Dermatology 1997 109 4 562 565 2-s2.0-0030766567
20. Mössner R., Kingo K., Kleensang A., Krüger U., König I. R., Silm H., Westphal G. A., Reich K., Association of TNF -238 and -308 promoter polymorphisms with psoriasis vulgaris and psoriatic arthritis but not with pustulosis palmoplantaris. Journal of Investigative Dermatology 2005 124 1 282 284 2-s2.0-11944268318 10.1111/j.0022-202X.2004.23556.x
21. Louis E., Franchimont D., Piron A., Gevaert Y., Schaaf-Lafontaine N., Roland S., Mahieu P., Malaise M., De Groote D., Louis R., Belaiche J., Tumour necrosis factor (TNF) gene polymorphism influences TNF- α production in lipopolysaccharide (LPS)-stimulated whole blood cell culture in healthy humans. Clinical and Experimental Immunology 1998 113 3 401 406 2-s2.0-7344251714 10.1046/j.1365-2249.1998.00662.x
22. Li C., Wang G., Gao Y., Liu L., Gao T., TNF- α gene promoter -238G>A and -308G>A polymorphisms alter risk of psoriasis vulgaris: a meta-analysis. Journal of Investigative Dermatology 2007 127 8 1886 1892 2-s2.0-34447567035 10.1038/sj.jid.5700822
23. Kaluza W., Reuss E., Grossmann S., Hug R., Schopf R. E., Galle P. R., Maerker-Hermann E., Hoehler T., Different transcriptional activity and in vitro TNF- α production in psoriasis patients carrying the TNF- α 238A promoter polymorphism. Journal of Investigative Dermatology 2000 114 6 1180 1183 2-s2.0-0034099699 10.1046/j.1523-1747.2000.00001.x
24. Reich K., Mössner R., König I. R., Westphal G., Ziegler A., Neumann C., Promoter polymorphisms of the genes encoding tumor necrosis factor- α and interleukin-1 β are associated with different subtypes of psoriasis characterized by early and late disease onset. Journal of Investigative Dermatology 2002 118 1 155 163 2-s2.0-0036153555 10.1046/j.0022-202x.2001.01642.x
25. Settin A., Hassan H., El-Baz R., Hassan T., Association of cytokine gene polymorphisms with psoriasis in cases from the Nile Delta of Egypt. Acta Dermatovenerologica Alpina, Pannonica et Adriatica 2009 18 3 105 112 2-s2.0-70350166548
26. Kim T.-G., Pyo C.-W., Hur S.-S., Kim Y.-K., Hwang H.-Y., Youn J.-I., Kim T.-Y., Polymorphisms of tumor necrosis factor (TNF) α and β genes in Korean patients with psoriasis. Archives of Dermatological Research 2003 295 1 8 13 2-s2.0-0038290694
27. Reich K., Westphal G., Schulz T., Müller M., Zipprich S., Fuchs T., Hallier E., Neumann C., Combined analysis of polymorphisms of the tumor necrosis factor- α and interleukin-10 promoter regions and polymorphic xenobiotic metabolizing enzymes in psoriasis. Journal of Investigative Dermatology 1999 113 2 214 220 2-s2.0-0033498767 10.1046/j.1523-1747.1999.00654.x
28. Nedoszytko B., Szczerkowska-Dobosz A., Zabłotna M., Gleń J., Rbała K., Roszkiewicz J., Associations of promoter region polymorphisms in the tumour necrosis factor- α gene and early-onset psoriasis vulgaris in a northern Polish population. British Journal of Dermatology 2007 157 1 165 167 2-s2.0-34250687832 10.1111/j.1365-2133.2007. 07993.x
29. Arias A. I., Giles B., Eiermann T. H., Sterry W., Pandey J. P., Tumor necrosis factor-alpha gene polymorphism in psoriasis. Experimental and Clinical Immunogenetics 1997 14 2 118 122 2-s2.0-0030736865
30. Johansen C., Vinter H., Soegaard-Madsen L., Olsen L. R., Steiniche T., Iversen L., Kragballe K., Preferential inhibition of the mRNA expression of p38 mitogen-activated protein kinase regulated cytokines in psoriatic skin by anti-TNF α therapy. British Journal of Dermatology 2010 163 6 1194 1204 2-s2.0-78649668321 10.1111/j.1365-2133.2010.10036.x
31. Toussirot É., The IL23/Th17 pathway as a therapeutic target in chronic inflammatory diseases. Inflammation and Allergy 2012 11 2 159 168 2-s2.0-84857774124
32. Kurzeja M., Rudnicka L., Olszewska M., New interleukin-23 pathway inhibitors in dermatology: ustekinumab, briakinumab, and secukinumab. American Journal of Clinical Dermatology 2011 12 2 113 125 2-s2.0-79952213941 10.2165/11538950-000000000-00000
33. Li Y., Begovich A. B., Unraveling the genetics of complex diseases: susceptibility genes for rheumatoid arthritis and psoriasis. Seminars in Immunology 2009 21 6 318 327 2-s2.0-70749127823 10.1016/j.smim.2009.04.002
34. Garcia V. E., Chang M., Brandon R., Li Y., Matsunami N., Callis-Duffin K. P., Civello D., Rowland C. M., Bui N., Catanese J. J., Krueger G. G., Leppert M. F., Begovich A. B., Schrodi S. J., Detailed genetic characterization of the interleukin-23 receptor in psoriasis. Genes and Immunity 2008 9 6 546 555 2-s2.0-51249086433 10.1038/gene.2008.55
35. Zhang X.-J., Enlightenment from genome-wide association study to genetics of psoriasis. Journal of Zhejiang University 2009 38 4 333 337 2-s2.0-77950347419
36. Nair R. P., Ruether A., Stuart P. E., Jenisch S., Tejasvi T., Hiremagalore R., Schreiber S., Kabelitz D., Lim H. W., Voorhees J. J., Christophers E., Elder J. T., Weichenthal M., Polymorphisms of the IL12B and IL23R genes are associated with psoriasis. Journal of Investigative Dermatology 2008 128 7 1653 1661 2-s2.0-42149140747 10.1038/sj.jid.5701255
37. Cargill M., Schrodi S. J., Chang M., Garcia V. E., Brandon R., Callis K. P., Matsunami N., Ardlie K. G., Civello D., Catanese J. J., Leong D. U., Panko J. M., McAllister L. B., Hansen C. B., Papenfuss J., Prescott S. M., White T. J., Leppert M. F., Krueger G. G., Begovich A. B., A large-scale genetic association study confirms IL12B and leads to the identification of IL23R as psoriasis-risk genes. American Journal of Human Genetics 2007 80 2 273 290 2-s2.0-33846608131 10.1086/511051
38. Nair R. P., Stuart P. E., Kullavanijaya P., Kullavanijaya P., Tejasvi T., Voorhees J. J., Elder J. T., Genetic evidence for involvement of the IL23 pathway in Thai psoriatics. Archives of Dermatological Research 2010 302 2 139 143 2-s2.0-77449161010 10.1007/s00403-009-0986-y
39. Wu Y., Lu Z., Chen Y., Xue F., Chen X., Zheng J., Replication of association between interleukin-23 receptor (IL-23R) and its ligand (IL-12B) polymorphisms and psoriasis in the Chinese Han population. Human Immunology 2010 71 12 1255 1258 2-s2.0-78149407645 10.1016/j.humimm.2010.09.014
40. Capon F., Di Meglio P., Szaub J., Prescott N. J., Dunster C., Baumber L., Timms K., Gutin A., Abkevic V., Burden A. D., Lanchbury J., Barker J. N., Trembath R. C., Nestle F. O., Sequence variants in the genes for the interleukin-23 receptor (IL23R) and its ligand (IL12B) confer protection against psoriasis. Human Genetics 2007 122 2 201 206 2-s2.0-34547774225 10.1007/s00439-007-0397-0
41. Smith R. L., Warren R. B., Eyre S., Ho P., Ke X., Young H. S., Griffiths C. E. M., Worthington J., Polymorphisms in the IL-12 β and IL-23R genes are associated with psoriasis of early onset in a UK cohort. Journal of Investigative Dermatology 2008 128 5 1325 1327 2-s2.0-42149150968 10.1038/sj.jid.5701140
42. Liu Y., Helms C., Liao W., Zaba L. C., Duan S., Gardner J., Wise C., Miner A., Malloy M. J., Pullinger C. R., Kane J. P., Saccone S., Worthington J., Bruce I., Kwok P.-Y., Menter A., Krueger J., Barton A., Saccone N. L., Bowcock A. M., A genome-wide association study of psoriasis and psoriatic arthritis identifies new disease loci. PLoS Genetics 2008 4 3 e1000041 2-s2.0-44949172789 10.1371/journal.pgen.1000041
43. Hüffmeier U., Lascorz J., Böhm B., Lohmann J., Wendler J., Mössner R., Reich K., Traupe H., Kurrat W., Burkhardt H., Reis A., Genetic variants of the IL-23R pathway: association with psoriatic arthritis and psoriasis vulgaris, but no specific risk factor for arthritis. Journal of Investigative Dermatology 2009 129 2 355 358 2-s2.0-58549093348 10.1038/jid.2008.233
44. Nair R. P., Duffin K. C., Helms C., Ding J., Stuart P. E., Goldgar D., Gudjonsson J. E., Li Y., Tejasvi T., Feng B.-J., Ruether A., Schreiber S., Weichenthal M., Gladman D., Rahman P., Schrodi S. J., Prahalad S., Guthery S. L., Fischer J., Liao W., Kwok P.-Y., Menter A., Lathrop G. M., Wise C. A., Begovich A. B., Voorhees J. J., Elder J. T., Krueger G. G., Bowcock A. M., Abecasis G. R., Genome-wide scan reveals association of psoriasis with IL-23 and NF- B pathways. Nature Genetics 2009 41 2 199 204 2-s2.0-59149106117 10.1038/ng.311
45. Ellinghaus E., Ellinghaus D., Stuart P. E., Nair R. P., Debrus S., Raelson J. V., Belouchi M., Fournier H., Reinhard C., Ding J., Li Y., Tejasvi T., GudjonSon J., Stoll S. W., Voorhees J. J., Lambert S., Weidinger S., Eberlein B., Kunz M., Rahman P., Gladman D. D., Gieger C., WichmaN H. E., Karlsen T. H., Mayr G., Albrecht M., Kabelitz D., Mrowietz U., Abecasis G. R., Elder J. T., Schreiber S., Weichenthal M., Franke A., Genome-wide association study identifies a psoriasis susceptibility locus at TRAF3IP2. Nature Genetics 2010 42 11 991 995 2-s2.0-78049343768 10.1038/ng.689
46. Tsunemi Y., Saeki H., Nakamura K., Sekiya T., Hirai K., Fujita H., Asano N., Kishimoto M., Tanida Y., Kakinuma T., Mitsui H., Tada Y., Wakugawa M., Torii H., Komine M., Asahina A., Tamaki K., Interleukin-12 p40 gene (IL12B) 3′-untranslated region polymorphism is associated with susceptibility to atopic dermatitis and psoriasis vulgaris. Journal of Dermatological Science 2002 30 2 161 166 2-s2.0-12244281852 10.1016/S0923-1811(02)00072-5
47. Musone S. L., Taylor K. E., Nititham J., Chu C., Poon A., Liao W., Lam E. T., Ma A., Kwok P.-Y., Criswell L. A., Sequencing of TNFAIP3 and association of variants with multiple autoimmune diseases. Genes and Immunity 2011 12 3 176 182 2-s2.0-79955471681 10.1038/gene.2010.64
48. Lodolce J. P., Kolodziej L. E., Rhee L., Kariuki S. N., Franek B. S., McGreal N. M., Logsdon M. F., Bartulis S. J., Perera M. A., Ellis N. A., Adams E. J., Hanauer S. B., Jolly M., Niewold T. B., Boone D. L., African-derived genetic polymorphisms in TNFAIP3 mediate risk for autoimmunity. Journal of Immunology 2010 184 12 7001 7009 2-s2.0-77953639241 10.4049/jimmunol.1000324
49. Hüffmeier U., Uebe S., Ekici A. B., Bowes J., Giardina E., Korendowych E., Juneblad K., Apel M., McManus R., Ho P., Bruce I. N., Ryan A. W., Behrens F., Lascorz J., Böhm B., Traupe H., LohmaN J., Gieger C., Wichman H.-E., Herold C., Steffens M., Klareskog L., Wienker T. F., FitzGerald O., Alenius G.-M., McHugh N. J., Novelli G., Burkhardt H., Barton A., Reis A., Comon variants at TRAF3IP2 are asociated with susceptibility to psoriatic arthritis and psoriasis. Nature Genetics 2010 42 11 996 999 2-s2.0-78049350350 10.1038/ng.688
50. Strange A., Capon F., Spencer C. C. A., Knight J., Weale M. E., Allen M. H., Barton A., Band G., Bellenguez C., Bergboer J. G. M., BlackweL J. M., Bramon E., Bumpstead S. J., Casas J. P., Cork M. J., Corvin A., Deloukas P., Dilthey A., Duncanson A., Edkins S., EstiviL X., Fitzgerald O., FrEman C., Giardina E., Gray E., Hofer A., Hüffmeier U., Hunt S. E., Irvine A. D., Jankowski J., Kirby B., Langford C., Lascorz J., Leman J., Leslie S., MaLbris L., Markus H. S., Mathew C. G., McLean W. H. I., McManus R., MöSner R., Moutsianas L., Naluai A. T., Nestle F. O., NoveLi G., Onoufriadis A., Palmer C. N. A., Perricone C., Pirinen M., Plomin R., PoTer S. C., Pujol R. M., Rautanen A., Riveira-Munoz E., Ryan A. W., Salmhofer W., SamuelSon L., Sawcer S. J., Schalkwijk J., Smith C. H., Ståhle M., Su Z., Tazi-Ahnini R., Traupe H., Viswanathan A. C., Warren R. B., Weger W., Wolk K., WOd N., Worthington J., Young H. S., Zeeuwen P. L. J. M., Hayday A., Burden A. D., Griffiths C. E. M., Kere J., Reis A., McVean G., Evans D. M., Brown M. A., Barker J. N., Peltonen L., Donely P., Trembath R. C., A genome-wide asociation study identifies new psoriasis susceptibility loci and an interaction betwEn HLA-C and ERAP1. Nature Genetics 2010 42 11 985 990 2-s2.0-78049347495 10.1038/ng.694
51. Feng B.-J., Sun L.-D., Soltani-Arabshahi R., Bowcock A. M., Nair R. P., Stuart P., Elder J. T., Schrodi S. J., Begovich A. B., Abecasis G. R., Zhang X.-J., Callis-Duffin K. P., Krueger G. G., Goldgar D. E., Multiple loci within the major histocompatibility complex confer risk of psoriasis. PLoS Genetics 2009 5 8 2-s2.0-70149090668 10.1371/journal.pgen.1000606 e1000606
52. Sun L. D., Cheng H., Wang Z. X., Association analyses identify six new psoriasis susceptibility loci in the Chinese population. Nature Genetics 2010 42 11 1005 1009
53. Kim Y.-K., Pyo C.-W., Choi H.-B., Kim S.-Y., Kim T.-Y., Kim T.-G., Associations of IL-2 and IL-4 gene polymorphisms with psoriasis in the Korean population. Journal of Dermatological Science 2007 48 2 133 139 2-s2.0-34548510144 10.1016/j.jdermsci.2007.06.014
54. Baran W., Szepietowski J. C., Mazur G., Baran E., IFN- γ promoter gene polymorphism in psoriasis vulgaris. Biomarkers 2008 13 1 52 58 2-s2.0-38049153095 10.1080/13547500701610273
55. Kanda N., Masahiro N., Tada Y., Ishikawa T., Sato S., Watanabe S., Human β -defensin-2 enhances IFN- γ and IL-10 production and suppresses IL-17 production in T cells. Journal of Leukocyte Biology 2011 89 6 935 944 2-s2.0-79957809530 10.1189/jlb.0111004
56. Hollox E. J., Huffmeier U., Zeeuwen P. L. J. M., Palla R., Lascorz J., Rodijk-Olthuis D., Van De Kerkhof P. C. M., Traupe H., De Jongh G., Heijer M. D., Reis A., Armour J. A. L., Schalkwijk J., Psoriasis is associated with increased β -defensin genomic copy number. Nature Genetics 2008 40 1 23 25 2-s2.0-37549033125 10.1038/ng.2007.48
57. Web page National Center for Biotecnology Information (NCBI), 2013, http://www.ncbi.nlm.nih.gov/gene
58. Kato T., Tsunemi Y., Saeki H., Shibata S., Sekiya T., Nakamura K., Kakinuma T., Kagami S., Fujita H., Tada Y., Sugaya M., Tamaki K., Interferon-18 gene polymorphism -137 G/C is associated with susceptibility to psoriasis vulgaris but not with atopic dermatitis in Japanese patients. Journal of Dermatological Science 2009 53 2 162 163 2-s2.0-57649213843 10.1016/j.jdermsci. 2008.08.016
59. Baran W., Szepietowski J. C., Mazur G., Baran E., IL-6 and IL-10 promoter gene polymorphisms in psoriasis vulgaris. Acta Dermato-Venereologica 2008 88 2 113 116 2-s2.0-41949106564 10.2340/00015555-0427
60. Craven N. M., Jackson C. W., Kirby B., Perrey C., Pravica V., Hutchinson I. V., Griffiths C. E. M., Cytokine gene polymorphisms in psoriasis. British Journal of Dermatology 2001 144 4 849 853 2-s2.0-0035030018 10.1046/j.1365-2133. 2001.04143.x
61. Chang M., Li Y., Yan C., Callis-Duffin K. P., Matsunami N., Garcia V. E., Cargill M., Civello D., Bui N., Catanese J. J., Leppert M. F., Krueger G. G., Begovich A. B., Schrodi S. J., Variants in the 5q31 cytokine gene cluster are associated with psoriasis. Genes and Immunity 2008 9 2 176 181 2-s2.0-40449113452 10.1038/sj.gene.6364451
62. Duffin K. C., Freeny I. C., Schrodi S. J., Wong B., Feng B.-J., Soltani-Arabshahi R., Rakkhit T., Goldgar D. E., Krueger G. G., Association between IL13 polymorphisms and psoriatic arthritis is modified by smoking. The Journal of investigative dermatology 2009 129 12 2777 2783 2-s2.0-79958169705
63. Bowes J., Eyre S., Flynn E., Ho P., Salah S., Warren R. B., Marzo-Ortega H., Coates L., McManus R., Ryan A. W., Kane D., Korendowych E., McHugh N., FitzGerald O., Packham J., Morgan A. W., Griffiths C. E. M., Bruce I. N., Worthington J., Barton A., Evidence to support IL-13 as a risk locus for psoriatic arthritis but not psoriasis vulgaris. Annals of the Rheumatic Diseases 2011 70 6 1016 1019 2-s2.0-79955846991 10.1136/ard.2010.143123
64. Kõks S., Kingo K., Rätsep R., Karelson M., Silm H., Vasar E., Combined haplotype analysis of the interleukin-19 and -20 genes: relationship to plaque-type psoriasis. Genes and Immunity 2004 5 8 662 667 2-s2.0-11044228418 10.1038/sj.gene.6364141
65. Chen X.-Y., Jin L.-W., Chen Y.-W., Tian H., Yuan W.-T., Niu Z.-M., Zhang J., Huang W., Zheng J., The association between the IL-20 -1723C→G allele on the 1q chromosome and psoriasis triggered or exacerbated by an upper respiratory tract infection in the Chinese Han population. Dermatology 2011 222 1 24 30 2-s2.0-79951678827 10.1159/000320772
66. Kingo K., Kõks S., Nikopensius T., Silm H., Vasar E., Polymorphisms in the interleukin-20 gene: relationships to plaque-type psoriasis. Genes and Immunity 2004 5 2 117 121 2-s2.0-1642354567 10.1038/sj.gene.6364046
67. Kingo K., Mössner R., Traks T., Rätsep R., Raud K., Reimann E., Krüger U., Silm H., Vasar E., Reich K., Kõks S., Further association analysis of chr 6q22-24 suggests a role of IL-20RA polymorphisms in psoriasis. Journal of Dermatological Science 2010 57 1 71 73 2-s2.0-72149120846 10.1016/j.jdermsci.2009.10.007
68. Kõks S., Kingo K., Vabrit K., Rätsep R., Karelson M., Silm H., Vasar E., Possible relations between the polymorphisms of the cytokines IL-19, IL-20 and IL-24 and plaque-type psoriasis. Genes and Immunity 2005 6 5 407 415 2-s2.0-30744458384 10.1038/sj.gene.6364216
69. Zhang X.-J., Yan K.-L., Wang Z.-M., Yang S., Zhang G.-L., Fan X., Xiao F.-L., Gao M., Cui Y., Wang P.-G., Sun L.-D., Zhang K.-Y., Wang B., Wang D.-Z., Xu S.-J., Huang W., Liu J.-J., Polymorphisms in interleukin-15 gene on chromosome 4q31.2 are associated with psoriasis vulgaris in Chinese population. Journal of Investigative Dermatology 2007 127 11 2544 2551 2-s2.0-35348829138 10.1038/sj.jid.5700896
70. Smith R. L., Eyre S., Warren R. B., Young H. S., Griffiths C. E. M., Worthington J., No association between polymorphisms in the interleukin-15 gene and early-onset psoriasis in a UK cohort suggests heterogeneity for this susceptibility locus identified in Chinese psoriasis patients. Journal of Investigative Dermatology 2008 128 12 2904 2905 2-s2.0-57349145907 10.1038/jid.2008.148
71. Wang L., Yang L., Gao L., Gao T. W., Li W., Liu Y. F., A functional promoter polymorphism in monocyte chemoattractant protein-1 is associated with psoriasis. International Journal of Immunogenetics 2008 35 1 45 49 2-s2.0-37849032330 10.1111/j.1744-313X.2007.00734.x
72. Zervou M. I., Goulielmos G. N., Castro-Giner F., Tosca A. D., Krueger-Krasagakis S., STAT4 gene polymorphism is associated with psoriasis in the genetically homogeneous population of Crete, Greece. Human Immunology 2009 70 9 738 741 2-s2.0-68749099367 10.1016/j.humimm.2009.05.008
73. Karpouzis A., Caridha R., Tripsianis G., Michailidis C., Martinis G., Veletza S. V., Apolipoprotein e gene polymorphism in psoriasis. Archives of Dermatological Research 2009 301 6 405 410 2-s2.0-68149172942 10.1007/s00403-009-0968-0
74. Coto-Segura P., Coto E., Alvarez V., Morales B., Soto-Sánchez J., Corao A. I., Santos-Juanes J., Apolipoprotein ε 4 allele is associated with psoriasis severity. Archives of Dermatological Research 2010 302 2 145 149 2-s2.0-77449137667 10.1007/s00403-009-1002-2
75. Campalani E., Allen M. H., Fairhurst D., Young H. S., Mendonca C. O., Burden A. D., Griffiths C. E. M., Crook M. A., Barker J. N. W. N., Smith C. H., Apolipoprotein E gene polymorphisms are associated with psoriasis but do not determine disease response to acitretin. British Journal of Dermatology 2006 154 2 345 352 2-s2.0-33644909060 10.1111/j.1365-2133.2005.06950.x
76. Halsall J. A., Osborne J. E., Pringle J. H., Hutchinson P. E., Vitamin D receptor gene polymorphisms, particularly the novel A-1012G promoter polymorphism, are associated with vitamin D3 responsiveness and non-familial susceptibility in psoriasis. Pharmacogenetics and Genomics 2005 15 5 349 355 2-s2.0-18744409798
77. Zuel-Fakkar N. M., Kamel M. M., Asaad M. K., Mahran M. Z., Shehab A. A., A study of ApaI and TaqI genotypes of the vitamin D receptor in Egyptian patients with psoriasis. Clinical and Experimental Dermatology 2011 36 4 355 359 2-s2.0-79955970763 10.1111/j.1365-2230.2010.03970.x
78. Rucevic I., Barisic-Drusko V., Glavas-Obrovac L., Stefanic M., Vitamin D endocrine system and psoriasis vulgaris-review of the literature. Acta Dermatovenerologica Croatica 2009 17 3 187 192
79. Dayangac-Erden D., Karaduman A., Erdem-Yurter H., Polymorphisms of vitamin D receptor gene in Turkish familial psoriasis patients. Archives of Dermatological Research 2007 299 10 487 491 2-s2.0-36348971128 10.1007/s00403-007-0782-5
80. Łuszczek W., Kubicka W., Jasek M., Baran E., Cisło M., Nockowski P., Łuczywo-Rudy M., Wiśniewski A., Nowak I., Kuśnierczyk P., CTLA-4 gene polymorphisms and natural soluble CTLA-4 protein in psoriasis vulgaris. International Journal of Immunogenetics 2006 33 3 217 224 2-s2.0-33646878291 10.1111/j.1744-313X.2006.00600.x
81. Łuszczek W., Majorczyk E., Nockowski P., Pluciński P., Jasek M., Nowak I., Wiśniewski A., Kuśnierczyk P., Distribution of the CTLA-4 single nucleotide polymorphisms CT60G>A and +49A>G in psoriasis vulgaris patients and control individuals from a Polish Caucasian population. International Journal of Immunogenetics 2008 35 1 51 55 2-s2.0-37849008454 10.1111/j.1744-313X.2007.00736.x
82. Kim Y.-K., Pyo C.-W., Hur S.-S., Kim T.-Y., Kim T.-G., No associations of CTLA-4 and ICAM-1 polymorphisms with psoriasis in the Korean population. Journal of Dermatological Science 2003 33 1 75 77 2-s2.0-0141758359 10.1016/S0923-1811(03)00159-2
83. Hébert H. L., Ali F. R., Bowes J., Griffiths C. E. M., Barton A., Warren R. B., Genetic susceptibility to psoriasis and psoriatic arthritis: implications for therapy. British Journal of Dermatology 2012 166 3 474 482 2-s2.0-84857578523 10.1111/j.1365-2133.2011.10712.x
84. Bowes J., Flynn E., Ho P., Aly B., Morgan A. W., Marzo-Ortega H., Coates L., McManus R., Ryan A. W., Kane D., Korendowych E., McHugh N., FitzGerald O., Packham J., Bruce I. N., Barton A., Variants in linkage disequilibrium with the late cornified envelope gene cluster deletion are associated with susceptibility to psoriatic arthritis. Annals of the Rheumatic Diseases 2010 69 12 2199 2203 2-s2.0-78649750839 10.1136/ard.2010.130575
85. Zhang X.-J., Huang W., Yang S., Sun L.-D., Zhang F.-Y., Zhu Q.-X., Zhang F.-R., Zhang C., Du W.-H., Pu X.-M., Li H., Xiao F.-L., Wang Z.-X., Cui Y., Hao F., Zheng J., Yang X.-Q., Cheng H., He C.-D., Liu X.-M., Xu L.-M., Zheng H.-F., Zhang S.-M., Zhang J.-Z., Wang H.-Y., Cheng Y.-L., Ji B.-H., Fang Q.-Y., Li Y.-Z., Zhou F.-S., Han J.-W., Quan C., Chen B., Liu J.-L., Lin D., Fan L., Zhang A.-P., Liu S.-X., Yang C.-J., Wang P.-G., Zhou W.-M., Lin G.-S., Wu W.-D., Fan X., Gao M., Yang B.-Q., Lu W.-S., Zhang Z., Zhu K.-J., Shen S.-K., Li M., Zhang X.-Y., Cao T.-T., Ren W., Zhang X., He J., Tang X.-F., Lu S., Yang J.-Q., Zhang L., Wang D.-N., Yuan F., Yin X.-Y., Huang H.-J., Wang H.-F., Lin X.-Y., Liu J.-J., Psoriasis genome-wide association study identifies susceptibility variants within LCE gene cluster at 1q21. Nature Genetics 2009 41 2 205 210 2-s2.0-59149096149 10.1038/ng.310
86. Docampo E., Giardina E., Riveira-Muñoz E., De Cid R., Escaramís G., Perricone C., Fernández-Sueiro J. L., Maymõ J., González-Gay M. A., Blanco F. J., Hüffmeier U., Lisbona M. P., Martín J., Carracedo Á., Reis A., Rabionet R., Novelli G., Estivill X., Deletion of LCE3C and LCE3B is a susceptibility factor for psoriatic arthritis: a study in Spanish and Italian populations and meta-analysis. Arthritis and Rheumatism 2011 63 7 1860 1865 2-s2.0-79959816293 10.1002/art.30340
87. Kircik L. H., Del Rosso J. Q., Anti-TNF agents for the treatment of psoriasis. Journal of Drugs in Dermatology 2009 8 6 546 559 2-s2.0-67650273032
88. Sivamani R. K., Correa G., Ono Y., Bowen M. P., Raychaudhuri S. P., Maverakis E., Biological therapy of psoriasis. Indian Journal of Dermatology 2010 55 2 161 170 2-s2.0-77952086525 10.4103/0019-5154.62754
89. Brand S., Crohn's disease: Th1, Th17 or both? The change of a paradigm: new immunological and genetic insights implicate Th17 cells in the pathogenesis of Crohn's disease. Gut 2009 58 8 1152 1167 2-s2.0-67650224449 10.1136/gut.2008.163667
90. Gandhi M., Alwawi E., Gordon K. B., Anti-p40 Antibodies Ustekinumab and Briakinumab: blockade of Interleukin-12 and Interleukin-23 in the Treatment of Psoriasis. Seminars in Cutaneous Medicine and Surgery 2010 29 1 48 52 2-s2.0-77951605086 10.1016/j.sder.2010.02.001
91. Wu J. J., Anti-interleukin-17 monoclonal antibody ixekizumab in psoriasis. New England Journal of Medicine 367 3 274 275
92. Rich P., Sigurgeirsson B., Thaci D., Ortonne J. P., Paul C., Schopf R. E., Morita A., Roseau K., Harfst E., Guettner A., Secukinumab induction and maintenance therapy in moderate-to-severe plaque psoriasis: a randomized, double-blind, placebo-controlled, phase II regimen-finding study. British Journal of Dermatology 2013 168 2 402 411
93. Papp K. A., Leonardi C., Menter A., Ortonne J.-P., Krueger J. G., Kricorian G., Aras G., Li J., Russell C. B., Thompson E. H. Z., Baumgartner S., Brodalumab, an anti-interleukin-17-receptor antibody for psoriasis. New England Journal of Medicine 2012 366 13 1181 1189 2-s2.0-84859017988 10.1056/NEJMoa1109017
94. Patel D. D., Lee D. M., Kolbinger F., Antoni C., Effect of IL-17A blockade with secukinumab in autoimmune diseases. Annals of the Rheumatic Diseases 2012
95. Leonardi C., Matheson R., Zachariae C., Cameron G., Li L., Edson-Heredia E., Braun D., Banerjee S., Anti-interleukin-17 monoclonal antibody ixekizumab in chronic plaque psoriasis. New England Journal of Medicine 2012 366 13 1190 1191 2-s2.0-84859073115 10.1056/NEJMoa1109997
96. Papp K. A., Langley R. G., Sigurgeirsson B., Abe M., Baker D. R., Konno P., Haemmerle S., Thurston H. J., Papavassilis C., Richards H. B., Efficacy and safety of secukinumab in the treatment of moderate-to-severe plaque psoriasis: a randomized, double-blind, placebo-controlled phase II dose-ranging study. British Journal of Dermatology 2013 168 2 412 421
97. Ports W. C., Khan S., Lan S., Lamba M., Bolduc C., Bissonnette R., Papp K., A randomised Phase 2a efficacy and safety trial of the topical Janus kinase inhibitor tofacitinib in the treatment of chronic plaque psoriasis. British Journal of Dermatology 2013
98. Menet C. J., Rompaey L. V., Geney R., Advances in the discovery of selective JAK inhibitors. Progress in Medicinal Chemistry 2013 52 153 223
99. Sanz M. J., Cortijo J., Morcillo E. J., PDE4 inhibitors as new anti-inflammatory drugs: effects on cell trafficking and cell adhesion molecules expression. Pharmacology and Therapeutics 2005 106 3 269 297 2-s2.0-19444363467 10.1016/j.pharmthera.2004.12.001
100. Papp K., Cather J. C., Rosoph L., Sofen H., Langley R. G., Matheson R. T., Hu C., Day R. M., Efficacy of apremilast in the treatment of moderate to severe psoriasis: a randomised controlled trial. Lancet 2012 380 9843 738 746
101. Bowes J., Barton A., The genetics of psoriatic arthritis: lessons from genome-wide association studies. Discovery Medicine 2010 10 52 177 183 2-s2.0-79952196921
102. Soriguer F., Morcillo S., Qué hacer cuando en los estudios de epidemiología biomolecular la distribución genotípica no se ajusta al equilibrio de Hardy-Weinberg. Endocrinología y Nutrición 2007 54 3 169 173
103. Zheng H.-F., Zuo X.-B., Lu W.-S., Li Y., Cheng H., Zhu K.-J., Yin X.-Y., Zhang C., Ren Y.-Q., Wang W.-J., Sun L.-D., Cui Y., Yang S., Zhang F.-Y., Zhang X.-J., Variants in MHC, LCE and IL12B have epistatic effects on psoriasis risk in Chinese population. Journal of Dermatological Science 2011 61 2 124 128 2-s2.0-78951496001 10.1016/j.jdermsci.2010.12.001
104. Zheng H.-F., Zhang C., Sun L.-D., Ni C., Zuo X.-B., Zhang Z., Lu W.-S., Xu S.-X., Han J.-W., Cheng H., Zhu K.-J., Cheng Y.-L., Yang S., Zhang F.-Y., Zhang X.-J., A single nucleotide polymorphism of MHC region is associated with subphenotypes of Psoriasis in Chinese population. Journal of Dermatological Science 2010 59 1 50 52 2-s2.0-77953614703 10.1016/j.jdermsci.2010.03.006
105. Capon F., Bijlmakers M.-J., Wolf N., Quaranta M., Huffmeier U., Allen M., Timms K., Abkevich V., Gutin A., Smith R., Warren R. B., Young H. S., Worthington J., Burden D. A., Griffiths C. E. M., Hayday A., Nestle F. O., Reis A., Lanchbury J., Barker J. N., Trembath R. C., Identification of ZNF313/RNF114 as a novel psoriasis susceptibility gene. Human Molecular Genetics 2008 17 13
106. Web page Hapmap, 2013, http://hapmap.ncbi.nlm.nih.gov/cgi-perl/gbrowse/ hapmap3r3-B36/#search
107. Web page Alfred, 2013, http://alfred.med.yale.edu/